Segment Information (Tables)
|
9 Months Ended |
Jun. 26, 2022 |
|---|
| Segment Reporting [Abstract] |
|
| Revenues, EBT, and Assets for reportable segments |
The table below presents revenues and EBT for reportable segments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
June 26,
2022 |
|
June 27,
2021 |
|
June 26,
2022 |
|
June 27,
2021 |
| Revenues |
|
|
|
|
|
|
|
| QCT |
$ |
9,378 |
|
|
$ |
6,472 |
|
|
$ |
27,773 |
|
|
$ |
19,287 |
|
| QTL |
1,519 |
|
|
1,489 |
|
|
4,917 |
|
|
4,762 |
|
| QSI |
8 |
|
|
11 |
|
|
22 |
|
|
30 |
|
| Reconciling items |
31 |
|
|
88 |
|
|
93 |
|
|
151 |
|
| Total |
$ |
10,936 |
|
|
$ |
8,060 |
|
|
$ |
32,805 |
|
|
$ |
24,230 |
|
| EBT |
|
|
|
|
|
|
|
| QCT |
$ |
2,996 |
|
|
$ |
1,795 |
|
|
$ |
9,450 |
|
|
$ |
5,299 |
|
| QTL |
1,080 |
|
|
1,053 |
|
|
3,640 |
|
|
3,514 |
|
| QSI |
(101) |
|
|
156 |
|
|
(248) |
|
|
412 |
|
| Reconciling items |
264 |
|
|
(747) |
|
|
(1,314) |
|
|
(2,236) |
|
| Total |
$ |
4,239 |
|
|
$ |
2,257 |
|
|
$ |
11,528 |
|
|
$ |
6,989 |
|
|
| Reconciling items for reportable segments - revenues |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
June 26,
2022 |
|
June 27,
2021 |
|
June 26,
2022 |
|
June 27,
2021 |
| Revenues |
|
|
|
|
|
|
|
| Nonreportable segments |
$ |
31 |
|
|
$ |
34 |
|
|
$ |
93 |
|
|
$ |
97 |
|
| Unallocated revenues (Note 2) |
— |
|
|
54 |
|
|
— |
|
|
54 |
|
|
$ |
31 |
|
|
$ |
88 |
|
|
$ |
93 |
|
|
$ |
151 |
|
| EBT |
|
|
|
|
|
|
|
| Unallocated revenues (Note 2) |
$ |
— |
|
|
$ |
54 |
|
|
$ |
— |
|
|
$ |
54 |
|
| Unallocated cost of revenues |
(76) |
|
|
(73) |
|
|
(182) |
|
|
(220) |
|
| Unallocated research and development expenses |
(408) |
|
|
(505) |
|
|
(1,294) |
|
|
(1,325) |
|
| Unallocated selling, general and administrative expenses |
(171) |
|
|
(125) |
|
|
(462) |
|
|
(418) |
|
| Unallocated other income (Note 2) |
1,059 |
|
|
— |
|
|
1,059 |
|
|
— |
|
| Unallocated interest expense (Note 6) |
(69) |
|
|
(138) |
|
|
(345) |
|
|
(420) |
|
| Unallocated investment and other (expense) income, net |
(58) |
|
|
55 |
|
|
(68) |
|
|
140 |
|
| Nonreportable segments |
(13) |
|
|
(15) |
|
|
(22) |
|
|
(47) |
|
|
$ |
264 |
|
|
$ |
(747) |
|
|
$ |
(1,314) |
|
|
$ |
(2,236) |
|
|
| Reconciling items for reportable segments - EBT |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
June 26,
2022 |
|
June 27,
2021 |
|
June 26,
2022 |
|
June 27,
2021 |
| Revenues |
|
|
|
|
|
|
|
| Nonreportable segments |
$ |
31 |
|
|
$ |
34 |
|
|
$ |
93 |
|
|
$ |
97 |
|
| Unallocated revenues (Note 2) |
— |
|
|
54 |
|
|
— |
|
|
54 |
|
|
$ |
31 |
|
|
$ |
88 |
|
|
$ |
93 |
|
|
$ |
151 |
|
| EBT |
|
|
|
|
|
|
|
| Unallocated revenues (Note 2) |
$ |
— |
|
|
$ |
54 |
|
|
$ |
— |
|
|
$ |
54 |
|
| Unallocated cost of revenues |
(76) |
|
|
(73) |
|
|
(182) |
|
|
(220) |
|
| Unallocated research and development expenses |
(408) |
|
|
(505) |
|
|
(1,294) |
|
|
(1,325) |
|
| Unallocated selling, general and administrative expenses |
(171) |
|
|
(125) |
|
|
(462) |
|
|
(418) |
|
| Unallocated other income (Note 2) |
1,059 |
|
|
— |
|
|
1,059 |
|
|
— |
|
| Unallocated interest expense (Note 6) |
(69) |
|
|
(138) |
|
|
(345) |
|
|
(420) |
|
| Unallocated investment and other (expense) income, net |
(58) |
|
|
55 |
|
|
(68) |
|
|
140 |
|
| Nonreportable segments |
(13) |
|
|
(15) |
|
|
(22) |
|
|
(47) |
|
|
$ |
264 |
|
|
$ |
(747) |
|
|
$ |
(1,314) |
|
|
$ |
(2,236) |
|
|